CURANUM AG

euro adhoc: Curanum AG
Financial Figures/Balance Sheet
CURANUM AG - EBITDA climbs to EUR 8.1 in the first quarter

@@start.t1@@--------------------------------------------------------------------------------   Disclosure announcement transmitted by euro adhoc. The issuer is responsible   for the content of this announcement. --------------------------------------------------------------------------------@@end@@

3-month report/First Quarter 07

10.05.2007

Revenue in the first quarter of 2007 rose from EUR50.9 million to EUR56.6 million, representing an increase of 11.2%. The rise reflects the contribution made by the FAZIT Group, which was acquired in September 2006, and by the Seniorenresidenz Armbrustergasse in Vienna, which was consolidated for the first time in November. First-quarter revenue was in line with our expectations, although occupancy was approximately one percentage point lower than in the first quarter of the previous year.

Earnings before interest, tax, depreciation and amortization (EBITDA) rose from EUR7.4 million to EUR8.1 million, corresponding to an increase of 9.5%. The EBITDA margin fell slightly as a consequence, and declined from 14.5% in the first quarter of 2006 to 14.3% in the first quarter of 2007.

The consolidations performed in the 2006 annual financial statements as well as the capitalization required by IFRS of customer bases purchased as part of corporate acquisitions, resulted in an above-average rate of increase in depreciation and amortization in the first quarter. These will reduce partially in the course of the financial year, since the amortization period for the customer bases is in part very brief, and there are also plans to dispose of real estate. Amortization and depreciation overall rose from EUR1.6 million in 2006 to EUR2.1 million in the first quarter of 2007, with the increase arising entirely from the above-described effects.

Growth in earnings before interest and tax (EBIT) was correspondingly less strong, with an increase from EUR5.8 million to EUR6.0 million. The EBIT margin fell from 11.4% in the first quarter of 2006 to 10.6% in the first quarter of 2007. The higher level of debt in the reporting period just passed resulted in an increase of interest expense from EUR1.9 million to EUR2.2 million. The net financial result reduced from -EUR1.7 million in the reporting period of the previous year to -EUR2.0 million in the first quarter of 2007. Earnings before tax fell to EUR4.0 million (Q1 2006: EUR4.1 million), and earnings after tax amounted to EUR2.4 million (Q1 2006: EUR2.6 million). Earnings per share correspondingly fell from EUR0.09 to EUR0.08 per share.

In the view of a traditionally weak first quarter, we are confident to deliver our planned figures for the full financial year 2007 of EUR229.1m of sales, EUR33.7m EBITDA and EUR12.0m net profit.

Munich May 10, 2007

The Management Board

@@start.t2@@end of announcement                                                 euro adhoc 10.05.2007 08:19:15
--------------------------------------------------------------------------------@@end@@

ots Originaltext: Curanum AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
Bernd Rothe
Tel.: +49 (0)89 242065-60
E-Mail: bernd.rothe@curanum.de

Branche: Healthcare Providers
ISIN:      DE0005240709
WKN:        524070
Index:    CDAX, Classic All Share, Prime All Share, SDAX
Börsen:  Frankfurter Wertpapierbörse / regulated dealing/prime
              standard
              Bayerische Börse / regulated dealing
              Börse Berlin-Bremen / free trade
              Hamburger Wertpapierbörse / free trade
              Baden-Württembergische Wertpapierbörse / free trade
              Börse Düsseldorf / free trade



Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: